Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (5): 699-701    DOI: 10.12891/ceog4566.2018
Original Research Previous articles | Next articles
Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series
G. Genest1, *(), B. Elliott2, K. Spitzer3, C. A. Laskin4, W. Buckett5, L. Lapensée6, 7, I.J, Kadoch6, 7, P. Gol1
1 Department of Immunology, Montreal General Hospital, McGill University, Montreal, Canada
2 McGill University, Montreal, Canada
3 Trio Fertility, Toronto, ON, Canada
4 Department of Medicine and Obstetrics, University of Toronto, Toronto, Canada
5 Reproductive Centre, McGill University, Montreal, Canada
6 Department of Obstetrics and Gynecology, University of Montreal, Montreal, Canada
7 Department of Reproductive Medicine, Ovo Clinic, Montreal, Canada
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Intravenous Immunoglobulin (IVIg) is a potential treatment for immune mediated reproductive failure (IMRF), but its role in infertility treatments remains controversial. There is evidence that administering IVIg before conception improves pregnancy outcomes. In the present cohort, 13/15 (86%) patients had a live birth after receiving pre-conceptual IVIg at immunomodulatory doses. No serious maternal or fetal side effects directly attributable to IVIg were reported. The present results support the need for a randomized controlled trial (RCT) with this protocol.
Key words:  Immunology      Infertility      Maternal-fetal medicine     
Published:  10 October 2018     
*Corresponding Author(s):  G. GENEST     E-mail:  genevieve.genest@mail.mcgill.ca

Cite this article: 

G. Genest, B. Elliott, K. Spitzer, C. A. Laskin, W. Buckett, L. Lapensée, I.J, Kadoch, P. Gol. Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 699-701.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4566.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I5/699

[1] B.G. Kadioglu, B. Gundogdu, N. Kurt, A. Ozbek Bilgin, H. Suleyman, Z. Suleyman. The effect of rhodiola rosea root extract on stress-induced ovarian damage, infertility and reproductive disorders in female rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 530-536.
[2] S. J. Knight, A. D. Smith, H. Kim, A. C. Collier. Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 277-286.
[3] Hue HJ, Kim SK, Choi JY, Suh DH, Kim KD, No JH, Lee JR, Jee BC, Kim YB, Jeon HW. Previous ovarian surgery increases the risk of tubal factor infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 84-88.
[4] M. Minase, T. Miyamoto, N. Hayashi, G. Minase, K. Nishiwaki, K. Sengoku. A patient with a didelphys vaginal septum and infertility diagnosed by laparoscopy and magnetic resonance imaging[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 988-989.
[5] E.G. Aydeniz, U. Sari, T.U.K. Dilek. Pregnancy success rate at recurrent implantation failure patients after hysteroscopic endometrial injury: preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 709-712.
[6] J. Jeong, J. Yang, Y. J. Song, Y. J. Na, H. G. Kim. A case report of acute ovarian cyst torsion by female adnexal tumor of probable Wölffian origin[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 824-827.
[7] K. Kitaya, Y. Takaya, R. Nishiyama, K. Yamaguchi, H. Matsubayashi, T. Takeuchi, S. Mizuta, T. Ishikawa. Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 549-552.
[8] H. Kwon, J. E. Shin, H. Kim. A novel treatment of severe dysmenorrhea due to adenomyosis: a case series of 3 infertile patients treated with dopamine agonist and in vitro fertilization-embryo transfer resulting in successful pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 637-640.
[9] P. Fuchs, I. Czech, A. Fuchs, J. Sikora. Use of neutral argon plasma in the treatment of endometriosis initial findings[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 434-436.
[10] J.H. Check, J. Liss, D. Check. The beneficial effect of luteal phase support on pregnancy rates in women with unexplained infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 447-449.
[11] I. Rudic Biljic-Erski, M. Vasiljevic, S. Rakic, S. Mihajlovic, O.D. Smiljkovic. The impact of hysteroscopic myomectomy on fertility and pregnancy outcomes of infertile women according characteristics of submucous fibroids[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 235-240.
[12] Chunjuan Shen, Liping Wang, Xiaojie Wu, Shuhui Mao, Chunxia Fang. The relationship between vitamin D and IVF: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 12-15.
[13] Xiao-Li Zhang, Wei-ping Li, Zhong-Yu Liu, Yuan-Qing Yao, Hong-Xu. The auto-transplantation of uterus in swine: surgical techniques and long-term graft survival[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 21-26.
[14] Burcin Karamustafaoglu Balci, Bulent Ergun. Prevalence of low vitamin D levels in infertile patients – a single center pilot study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 104-107.
[15] M.M. Khadra, M.A. Freij, Z.A. Al-Mazaydeh, S.E. Al-Mashhrawi, B.O. Rahhal, S.S. Saleh, R.M. Kilani, L.H. Tahtamouni. Factors influencing successful pregnancy outcomes in IVF cycles among Jordanian infertile couples[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 855-860.
No Suggested Reading articles found!